• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未接受溶栓治疗的急性缺血性卒中患者症状性颅内出血的预测因素及预后:来自中国急性缺血性卒中治疗结局登记研究的数据分析

Predictors and Prognosis of Symptomatic Intracranial Hemorrhage in Acute Ischemic Stroke Patients Without Thrombolysis: Analysis of Data From the Chinese Acute Ischemic Stroke Treatment Outcome Registry.

作者信息

Shen Zhiyuan, Jin Haiqiang, Lu Yuxuan, Sun Wei, Liu Ran, Li Fan, Shu Junlong, Tai Liwen, Li Guozhong, Chen Huisheng, Zhang Guiru, Zhang Lei, Sun Xuwen, Qiu Jinhua, Wei Yan, Sun Weiping, Huang Yining

机构信息

Department of Neurology, Peking University First Hospital, Beijing, China.

Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang, China.

出版信息

Front Neurol. 2021 Sep 28;12:727304. doi: 10.3389/fneur.2021.727304. eCollection 2021.

DOI:10.3389/fneur.2021.727304
PMID:34650508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8506002/
Abstract

There is limited information on symptomatic intracranial hemorrhage (sICH) in stroke patients without thrombolysis. This study aimed to evaluate the risk factors of sICH and the association between sICH and the prognosis at 3 and 12 months in acute ischemic stroke patients without thrombolysis. Data originated from the Chinese Acute Ischemic Stroke Treatment Outcome Registry. Univariate analysis and multivariate logistic regression were used to screen the risk factors of sICH. Multivariable logistic regression models were used to assess the association of sICH with poor outcome and all-cause mortality. Totally, 9,484 patients were included, of which 69 (0.73%) had sICH. Atrial fibrillation (odds ratio [OR], 3.682; 95% confidence interval [CI], 1.945-6.971; < 0.001), history of tumors (OR, 2.956; 95% CI, 1.115-7.593; = 0.024), and the National Institutes of Health Stroke Scale (NIHSS) score on admission ([6-15: OR, 2.344; 95% CI, 1.365-4.024; = 0.002] [>15: OR, 4.731; 95% CI, 1.648-13.583; = 0.004]) were independently associated with sICH. After adjustment of the confounders, patients with sICH had a higher risk of poor outcome (OR, 1.983; 95% CI, 1.117-3.521; = 0.018) at 3 months and that of all-cause mortality at 3 (OR, 6.135; 95% CI, 2.328-16.169; < 0.001) and 12 months (OR, 3.720; 95% CI, 1.513-9.148; = 0.004). sICH occurred in 0.73% of acute ischemic stroke patients without thrombolysis and was associated with a worse prognosis at 3 and 12 months. Atrial fibrillation, history of tumors, and NIHSS score at admission were independent risk factors of sICH.

摘要

关于未接受溶栓治疗的中风患者出现症状性颅内出血(sICH)的信息有限。本研究旨在评估sICH的危险因素以及未接受溶栓治疗的急性缺血性中风患者在3个月和12个月时sICH与预后之间的关联。数据源自中国急性缺血性中风治疗结果登记处。采用单因素分析和多因素逻辑回归来筛选sICH的危险因素。使用多变量逻辑回归模型评估sICH与不良预后和全因死亡率之间的关联。总共纳入了9484例患者,其中69例(0.73%)发生了sICH。心房颤动(比值比[OR],3.682;95%置信区间[CI],1.945 - 6.971;P < 0.001)、肿瘤病史(OR,2.956;95% CI,1.115 - 7.593;P = 0.024)以及入院时的美国国立卫生研究院卒中量表(NIHSS)评分([6 - 15分:OR,2.344;95% CI,1.365 - 4.024;P = 0.002] [>15分:OR,4.731;95% CI,1.648 - 13.583;P = 0.004])与sICH独立相关。在对混杂因素进行调整后,发生sICH的患者在3个月时出现不良预后的风险更高(OR,1.983;95% CI,1.117 - 3.521;P = 0.018),在3个月(OR,6.135;95% CI,2.328 - 16.169;P < 0.001)和12个月(OR,3.720;95% CI,1.513 - 9.148;P = 0.004)时全因死亡率的风险更高。0.73%未接受溶栓治疗的急性缺血性中风患者发生了sICH,且与3个月和12个月时更差的预后相关。心房颤动、肿瘤病史和入院时的NIHSS评分是sICH的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57da/8506002/f59f88fd3e36/fneur-12-727304-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57da/8506002/f59f88fd3e36/fneur-12-727304-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57da/8506002/f59f88fd3e36/fneur-12-727304-g0001.jpg

相似文献

1
Predictors and Prognosis of Symptomatic Intracranial Hemorrhage in Acute Ischemic Stroke Patients Without Thrombolysis: Analysis of Data From the Chinese Acute Ischemic Stroke Treatment Outcome Registry.未接受溶栓治疗的急性缺血性卒中患者症状性颅内出血的预测因素及预后:来自中国急性缺血性卒中治疗结局登记研究的数据分析
Front Neurol. 2021 Sep 28;12:727304. doi: 10.3389/fneur.2021.727304. eCollection 2021.
2
A Nomogram to Predict Symptomatic Intracranial Hemorrhage After Intravenous Thrombolysis in Chinese Patients.预测中国患者静脉溶栓后症状性颅内出血的列线图
Neuropsychiatr Dis Treat. 2021 Jul 6;17:2183-2190. doi: 10.2147/NDT.S320574. eCollection 2021.
3
Prognosis and Predictors of Symptomatic Intracranial Hemorrhage After Endovascular Treatment of Large Vessel Occlusion Stroke.大血管闭塞性卒中血管内治疗后症状性颅内出血的预后及预测因素
Front Neurol. 2022 Jan 21;12:730940. doi: 10.3389/fneur.2021.730940. eCollection 2021.
4
Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.重组组织型纤溶酶原激活剂溶栓治疗急性缺血性脑卒中后院内死亡率及症状性颅内出血的风险预测因素。
J Stroke Cerebrovasc Dis. 2014 Jan;23(1):7-11. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.004. Epub 2012 May 11.
5
Predictors of Symptomatic Intracranial Hemorrhage after Endovascular Therapy in Acute Ischemic Stroke with Large Vessel Occlusion.急性缺血性卒中伴大血管闭塞血管内治疗后症状性颅内出血的预测因素
J Stroke Cerebrovasc Dis. 2017 Apr;26(4):766-771. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.015. Epub 2016 Nov 10.
6
Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis.与急性卒中全身溶栓后症状性出血转化相关的实验室因素。
J Neurol Sci. 2021 Jan 15;420:117265. doi: 10.1016/j.jns.2020.117265. Epub 2020 Dec 9.
7
Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke.急性缺血性卒中静脉注射阿替普酶溶栓后溶栓结局及症状性溶栓后出血的预测因素
J Neurosci Rural Pract. 2020 Apr;11(2):315-324. doi: 10.1055/s-0040-1709946. Epub 2020 May 2.
8
Efficacy and safety of thrombolysis for acute ischemic stroke with atrial fibrillation: a meta-analysis.溶栓治疗伴心房颤动的急性缺血性脑卒中的疗效和安全性:一项荟萃分析。
BMC Neurol. 2021 Feb 11;21(1):66. doi: 10.1186/s12883-021-02095-x.
9
Blood glucose to predict symptomatic intracranial hemorrhage after endovascular treatment of acute ischemic stroke with large infarct core: a prospective observational study.血糖预测大面积梗死核心急性缺血性卒中血管内治疗后症状性颅内出血:一项前瞻性观察研究。
Front Neurol. 2024 May 1;15:1367177. doi: 10.3389/fneur.2024.1367177. eCollection 2024.
10
Number of Retrieval Attempts Rather Than Procedure Time Is Associated With Risk of Symptomatic Intracranial Hemorrhage.检索尝试次数而非手术时间与症状性颅内出血风险相关。
Stroke. 2021 May;52(5):1580-1588. doi: 10.1161/STROKEAHA.120.031242. Epub 2021 Apr 5.

引用本文的文献

1
Prolonged Hospital Length of Stay Does Not Improve Functional Outcome in Acute Ischemic Stroke.急性缺血性卒中患者住院时间延长并不能改善功能结局。
Neurol Ther. 2025 Apr;14(2):593-607. doi: 10.1007/s40120-025-00712-2. Epub 2025 Feb 18.
2
Integrating Neutrophil-To-Albumin Ratio and Triglycerides: A Novel Indicator for Predicting Spontaneous Hemorrhagic Transformation in Acute Ischemic Stroke Patients.中性粒细胞与白蛋白比值和甘油三酯的整合:急性缺血性卒中患者自发性出血转化的新型预测指标。
CNS Neurosci Ther. 2024 Dec;30(12):e70133. doi: 10.1111/cns.70133.
3
A telemedicine-enabled intravenous thrombolytic treatment pathway for patients with hyperacute non-arteritic central retinal artery occlusion.

本文引用的文献

1
Association of calprotectin with other inflammatory parameters in the prediction of mortality for ischemic stroke.血清钙卫蛋白与其他炎症参数在预测缺血性脑卒中患者死亡率中的关系。
J Neuroinflammation. 2021 Jan 5;18(1):3. doi: 10.1186/s12974-020-02047-1.
2
CO combining power and outcomes in patients with acute ischaemic stroke or transient ischaemic attack.CO 联合急性缺血性脑卒中或短暂性脑缺血发作患者的疗效和结局。
Stroke Vasc Neurol. 2021 Jun;6(2):252-259. doi: 10.1136/svn-2020-000476. Epub 2020 Dec 9.
3
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
一种用于超急性非动脉性视网膜中央动脉阻塞患者的远程医疗静脉溶栓治疗途径。
Am J Ophthalmol Case Rep. 2024 Oct 20;36:102204. doi: 10.1016/j.ajoc.2024.102204. eCollection 2024 Dec.
4
Hemorrhagic Coagulation Disorders and Ischemic Stroke: How to Reconcile Both?出血性凝血障碍与缺血性卒中:如何协调二者?
Neurol Int. 2023 Nov 30;15(4):1443-1458. doi: 10.3390/neurolint15040093.
5
Early Hemorrhagic Transformation after Reperfusion Therapy in Patients with Acute Ischemic Stroke: Analysis of Risk Factors and Predictors.急性缺血性脑卒中患者再灌注治疗后的早期出血性转化:危险因素及预测因素分析
Brain Sci. 2023 May 22;13(5):840. doi: 10.3390/brainsci13050840.
6
Thrombolysis in central retinal artery occlusion: a retrospective observational study.视网膜中央动脉阻塞的溶栓治疗:一项回顾性观察研究。
J Neurol. 2023 Feb;270(2):891-897. doi: 10.1007/s00415-022-11439-7. Epub 2022 Oct 28.
204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
4
The Role of Hemorrhagic Transformation in Acute Ischemic Stroke Upon Clinical Complications and Outcomes.出血性转化在急性缺血性卒中临床并发症及预后中的作用。
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104898. doi: 10.1016/j.jstrokecerebrovasdis.2020.104898. Epub 2020 May 13.
5
Association between non-high-density lipoprotein cholesterol and haemorrhagic transformation in patients with acute ischaemic stroke.非高密度脂蛋白胆固醇与急性缺血性脑卒中患者出血性转化的关系。
BMC Neurol. 2020 Feb 7;20(1):47. doi: 10.1186/s12883-020-1615-9.
6
Radiological predictors of hemorrhagic transformation after acute ischemic stroke: An evidence-based analysis.急性缺血性卒中后出血转化的影像学预测因素:一项基于证据的分析。
Neuroradiol J. 2020 Apr;33(2):118-133. doi: 10.1177/1971400919900275. Epub 2020 Jan 23.
7
Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: A systematic review and meta-analysis.双重抗血小板预处理对接受 IV 溶栓治疗的缺血性脑卒中患者的安全性和疗效:系统评价和荟萃分析。
Neurology. 2020 Feb 18;94(7):e657-e666. doi: 10.1212/WNL.0000000000008961. Epub 2020 Jan 20.
8
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.急性缺血性脑卒中患者早期管理指南:2018 年急性缺血性脑卒中早期管理指南的更新:美国心脏协会/美国卒中协会发布的医疗保健专业人员指南。
Stroke. 2019 Dec;50(12):e344-e418. doi: 10.1161/STR.0000000000000211. Epub 2019 Oct 30.
9
Management of oral anticoagulation in very old patients with non valvular atrial fibrillation related acute ischemic stroke.高龄非瓣膜性心房颤动相关急性缺血性脑卒中患者的口服抗凝药物管理。
J Thromb Thrombolysis. 2020 Jan;49(1):86-93. doi: 10.1007/s11239-019-01972-0.
10
Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke.中国急性缺血性脑卒中患者溶栓后症状性颅内出血的预测因素
PLoS One. 2017 Sep 18;12(9):e0184646. doi: 10.1371/journal.pone.0184646. eCollection 2017.